<DOC>
	<DOC>NCT00125294</DOC>
	<brief_summary>A dose titration protocol for sublingual methadone hydrochloride for the management of cancer-related breakthrough pain to find the optimal dose.</brief_summary>
	<brief_title>Sublingual Methadone for the Management of Cancer Breakthrough Pain</brief_title>
	<detailed_description>This is a dose titration protocol for sublingual methadone hydrochloride for the management of cancer-related breakthrough pain to find the optimal dose.</detailed_description>
	<mesh_term>Breakthrough Pain</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>&gt; 18 years of age Experiences episodes of breakthrough pain which respond to opioid therapy Controlled baseline pain Cognitive status sufficient for accurate completion of assessment form Willing to provide written informed consent Ability to hold a volume of 1 cc of water under the tongue for 5 minutes Currently or has received methadone during the previous week Recent history of substance abuse Severe respiratory impairment or other contraindications to opioids Recently received therapies that had the potential to alter pain intensity or response to analgesics Symptomatic anemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>cancer pain</keyword>
	<keyword>breakthrough pain</keyword>
	<keyword>methadone</keyword>
	<keyword>dose titration</keyword>
	<keyword>sublingual route of administration</keyword>
	<keyword>Cancer related pain</keyword>
	<keyword>currently taking narcotics</keyword>
</DOC>